Navigation Links
Hutchinson Center scientists net $16.7 million for stem cell research
Date:10/8/2009

SEATTLE The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center. The Hutchinson Center grants represent part of a $170 million effort involving 18 teams of research scientists dedicated to developing stem- and progenitor-cell tools and therapies.

The seven-year awards create the NHLBI Progenitor Cell Biology Consortium, which assembles nine research hubs with multidisciplinary teams of principal investigators and an administrative coordinating center.

While a stem cell can renew itself indefinitely or differentiate, a progenitor cell can only divide a limited number of times and is often more constrained than a stem cell in the kinds of cells it can become. Given the potential of these cells for clinical applications, the consortium aims to identify and characterize progenitor cell lines, direct the differentiation of stem and progenitor cells to desired cell fates, and develop new clinical strategies to address the unique challenges presented by the transplantation of these cells.

Torok-Storb, along with Fred Hutchinson/University of Washington Cancer Consortium colleagues, will collaborate with Mortimer Poncz, M.D., of Children's Hospital of Philadelphia to develop molecular- and cell-based therapies for a range of blood diseases, with an initial focus on the delayed recovery of blood-clotting platelets following stem-cell transplantation, a life-threatening complication called thrombocytopenia.

The partner institutions will focus on two complementary strategies to address delayed platelet production. With their $8.2 million grant, Torok-Storb's team will develop reagents that can be administered to patients to stimulate the differentiation and proliferation of precursor cells into platelets. The Philadelphia group will work to generate "ex vivo," or outside the body, platelets and their precursors from embryonic stem cells for use as cell therapy.

Bernstein, along with Hutchinson Center/UW Cancer Consortium researchers and the University of Pennsylvania's Edward Morrisey, Ph.D., is using his $8.5 million award to determine how certain signaling pathwaysordered sequences of biochemical reactions inside cellsaffect cardiac and blood-forming cell development and cardiac regeneration and repair. The team will also study whether these pathways can be harnessed for therapeutic applications. Drawing on Bernstein's success in expanding cord-blood stem cells, the researchers hope to refine methods for deriving therapeutically useful numbers of cells for transplantation and other treatments.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. Federal stimulus funding channels more than $40 million to Fred Hutchinson Cancer Research Center
2. Federal Stimulus Funding Channels More Than $40 Million to Fred Hutchinson Cancer Research Center
3. Hutchinson Metro Center Announces Over 50,000 SF in New Leases for Medical Space at Bronx Complex
4. Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award
5. Kevin Hutchinson Appointed to Health IT Standards Committee
6. Gastroenterologists Applaud Kennedy-Hutchinson Bills Renewal of War on Cancer
7. Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative
8. Fred Hutchinson Cancer Research Center Benefits From Shopping Site
9. Fred Hutchinson Cancer Research Centers Inaugural Big Expedition for Cancer Research Begins in Alaska
10. Human-Research Protection Program at Fred Hutchinson Cancer Research Center Receives National Accreditation
11. Fred Hutchinson Cancer Research Centers Big Expedition for Cancer Research Team Returns From Reconnaissance Flight Over Alaskas Glacier Bay Park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... GA (PRWEB) , ... December 06, 2016 , ... ... of largest patient satisfaction measurement firms. The ranking is based on reported ... organizations such as hospitals, health systems, ambulatory surgical centers, clinically integrated networks, and ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center ... recognizing the organization as a top behavioral service provider in the country. The ... quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via ...
(Date:12/6/2016)... ... ... Just in time for the holiday season, the celebrated paleo and gluten-free ... new Organic Quinoa Flour product for sale at Costco stores throughout the northwest region ... “I think it’s wonderful that a growing number of retailers such as Costco are ...
(Date:12/6/2016)... ... 06, 2016 , ... Keeping Gift Season Safe, In a season stacked with ... age-appropriate for their recipients. This is the idea behind Safe Toys and Gifts Month, ... that would make good gifts for children. For companies that produce goods that fall ...
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and light leaks ... flare from clip to clip with high quality 4K lens flare footage," said Christina ... 44 lens flares filmed on the RED Dragon. Utilizing the Dragon Sensor, TransFlare 4K ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... R&D program in the use of cannabinoids for ... In June, 2015 InMed initiated its COPD program ... targets and potential active compounds that can be ... in vitro assays using human lung fibroblasts (HFL-1 ...
(Date:12/6/2016)... Dec. 6, 2016  In response to the tragic ... every 25 minutes, a respected group of local and ... provide a holistic suite of services to help Medicaid-eligible ... on his own experience trying to help family and ... Justin Lanning launched 180 Health Partners ...
(Date:12/5/2016)... YORK , Dec. 5, 2016  Balloon catheter ... catheter, which is inserted into the femoral artery in ... the arm to treat constricted blood vessels. These products ... due to atherosclerosis – deposition of lipid substances in ... balloon catheter market is projected to expand at a ...
Breaking Medicine Technology: